CNN Money:Anavex Announces Positive Primary and Secondary Endpoints Were Achieved in a Phase 2a Clinical Trial of ANAVEX 2-73 in Alzheimer's Disease Anavex Announces Positive Primary and Secondary Endpoints Were Achieved in a Phase 2a Clinical Trial of ANAVEX 2-73 in Alzheimer's Disease